Likarda Announces Core Shell Spherification for Large Molecule Biologics and Welcomes New CEO, Dr. Stella Vnook
View the full release here: https://www.businesswire.com/news/home/20230913269537/en/
- View the full release here: https://www.businesswire.com/news/home/20230913269537/en/
To steer the company into this exciting new phase, Likarda is delighted to introduce Dr. Stella Vnook as the new CEO. - (Photo: Business Wire)
In a significant move for the biologics industry, Likarda is proud to announce two major developments: the expansion of its Core Shell Spherification (CSS) technology and the appointment of Dr. Stella Vnook as the new CEO. - This innovative approach will now design and produce delivery systems for large molecule biologics, including antibodies and peptides.
- To steer the company into this exciting new phase, Likarda is delighted to introduce Dr. Stella Vnook as the new CEO.